ACR Convergence 2023 Highlights: Two-week Break in Methotrexate Treatment and COVID-19 Vaccine Response: Vaccine Response On Off Methotrexate (VROOM) Study

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ACR Convergence 2023 Highlights: Two-week Break in Methotrexate Treatment and COVID-19 Vaccine Response: Vaccine Response On Off Methotrexate (VROOM) Study

By Highlights from ACR Convergence 2023 FEATURING Abhishek Abhishek

145 views

November 20, 2023

The above content is not sponsored by, nor part of, the American College of Rheumatology. ...
read more ↘

View American College of Rheumatology educational opportunities here https://rheumatology.org/events-programs
↖ read less

0 Comments

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

Feat. J. Cush